<?xml version="1.0" encoding="UTF-8"?>
<p>Several experiments and clinical investigations have shown the antiparasitic and adjuvant properties of the hydroalcoholic extract of propolis (HEP). HEP of different types of propolis showed antiparasitary efficacy against 
 <italic>Giardia lamblia</italic> [
 <xref rid="pone.0191797.ref020" ref-type="bibr">20</xref>,
 <xref rid="pone.0191797.ref021" ref-type="bibr">21</xref>], 
 <italic>Toxoplasma gondii</italic> and 
 <italic>Trichomonas vaginalis</italic> [
 <xref rid="pone.0191797.ref022" ref-type="bibr">22</xref>]. It is important to highlight that 
 <italic>T</italic>. 
 <italic>vaginalis</italic> is the etiological agent of trichomoniasis, the most common non-viral, sexually transmitted disease (STD) in the world [
 <xref rid="pone.0191797.ref023" ref-type="bibr">23</xref>]. In addition, metronidazole-resistant T. vaginalis has been implicated in an increasing number of refractory cases, which are usually treated with increased doses of the drug, leading to an increase in the occurrence of side effects [
 <xref rid="pone.0191797.ref024" ref-type="bibr">24</xref>]. Clearly, alternative curative therapies are needed, and propolis emerges as a natural product for alternative drugs.
</p>
